ES2494617A1 - Uso de la Garvicina A como producto antimicrobiano - Google Patents

Uso de la Garvicina A como producto antimicrobiano Download PDF

Info

Publication number
ES2494617A1
ES2494617A1 ES201300260A ES201300260A ES2494617A1 ES 2494617 A1 ES2494617 A1 ES 2494617A1 ES 201300260 A ES201300260 A ES 201300260A ES 201300260 A ES201300260 A ES 201300260A ES 2494617 A1 ES2494617 A1 ES 2494617A1
Authority
ES
Spain
Prior art keywords
garvicin
antimicrobial product
antimicrobial
product
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201300260A
Other languages
English (en)
Other versions
ES2494617B1 (es
Inventor
Alicia Gibello Prieto
Mª Del Mar BLANCO GUTIÉRREZ
Juan Miguel Rodríguez Gómez
Nivia CARDENAS CARDENAS
José Francisco FERNÁNDEZ-GARAYZABAL FERNÁNDEZ
Lucas José DOMÍNGUEZ RODRÍGUEZ
Antonio Maldonado Barragán
Mª Carmen ASPIROZ SANCHO
Ana Isabel DE LAS HERAS SÁNCHEZ
Juan José INFANTE VIÑOLO
Víctor Manuel INFANTE VIÑOLO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIONATURIS
Universidad Complutense de Madrid
Original Assignee
BIONATURIS
Universidad Complutense de Madrid
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIONATURIS, Universidad Complutense de Madrid filed Critical BIONATURIS
Priority to ES201300260A priority Critical patent/ES2494617B1/es
Priority to CN201480024715.9A priority patent/CN105188730A/zh
Priority to PCT/ES2014/000027 priority patent/WO2014140391A1/es
Publication of ES2494617A1 publication Critical patent/ES2494617A1/es
Application granted granted Critical
Publication of ES2494617B1 publication Critical patent/ES2494617B1/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A23B2/7295—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Uso de la Garvicina A como producto antimicrobiano. La invención consiste en el uso de la Garvicina A como producto antimicrobiano la forma de obtención de la Garvicina A mediante aislamiento natural o de manera recombinante, así como la aplicación de formulaciones que comprenden Garvicina A como compuesto antimicrobiano de uso en salud animal, salud humana e industria alimentaria.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15
imagen16
imagen17
imagen18
imagen19
imagen20
imagen21
imagen22

Claims (1)

  1. imagen1
    imagen2
ES201300260A 2013-03-15 2013-03-15 Uso de la Garvicina A como producto antimicrobiano Expired - Fee Related ES2494617B1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES201300260A ES2494617B1 (es) 2013-03-15 2013-03-15 Uso de la Garvicina A como producto antimicrobiano
CN201480024715.9A CN105188730A (zh) 2013-03-15 2014-03-03 用作抗菌产品的Garvicin A
PCT/ES2014/000027 WO2014140391A1 (es) 2013-03-15 2014-03-03 Uso de la garvicina a como producto antimicrobiano

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201300260A ES2494617B1 (es) 2013-03-15 2013-03-15 Uso de la Garvicina A como producto antimicrobiano

Publications (2)

Publication Number Publication Date
ES2494617A1 true ES2494617A1 (es) 2014-09-15
ES2494617B1 ES2494617B1 (es) 2015-06-11

Family

ID=51493128

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201300260A Expired - Fee Related ES2494617B1 (es) 2013-03-15 2013-03-15 Uso de la Garvicina A como producto antimicrobiano

Country Status (3)

Country Link
CN (1) CN105188730A (es)
ES (1) ES2494617B1 (es)
WO (1) WO2014140391A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102229939B (zh) * 2011-05-25 2013-01-23 青岛根源生物技术集团有限公司 一种优化的高活性人溶菌酶基因及其表达载体和应用

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
AGUADO-URDA, M. et al. ¿Characterization of plasmidsin a human clinical strain of Lactococcus garvieae¿.PLOS ONE. Junio 2012. Vol. 7, Nº 6, artículo e40119,páginas 1-16. Figura 6; Tabla 2. *
AGUADO-URDA, M. et al. ¿Genome sequence of Lactococcus garvieae 21881, isolated in a case of human septicemia¿.JOURNAL OF BACTERIOLOGY. 01.08.2011. Vol. 193, Nº1, páginas 4033-4034, todo el documento. *
BORRERO, J. et al. ¿Characterization of GarvicinML, a novel circular bacteriocin produced by Lactococcus garvieae DCC43, isolated from Mallard ducks (Anas platyrhynchos)¿. APPLIED AND ENVIRONMENTAL MICROBIOLOGY.01.01.2011. Vol. 77, Nº 1, páginas 369-373, todo el documento especialmente página 372, columna 2. *
CLEVELAND, J. et al. "Bacteriocins: safe, naturalantimicrobials for food preservation". INTERNATIONALJOURNAL OF FOOD MICROBIOLOGY. 04.12.2001. Vol. 71,N°. 1, páginas 1 - 20; todo el documento. *

Also Published As

Publication number Publication date
ES2494617B1 (es) 2015-06-11
CN105188730A (zh) 2015-12-23
WO2014140391A1 (es) 2014-09-18

Similar Documents

Publication Publication Date Title
WO2015184311A3 (en) Method of feeding an animal
MX2017010293A (es) 2-tioimidazolilcarboxamidas sustituidas como pesticidas.
MX2017005756A (es) Producto alimenticio para mascotas extruido.
CL2019003670A1 (es) Composición que comprende manosa oligosacárido y proceso para realizarla y uso de esta.
BR112015030268A2 (pt) composição farmacêutica, recipiente, kit, e, método para a preparação de uma composição
CL2018002645A1 (es) Sulfonamidas sustituidas para controlar plagas animales
JOP20200155B1 (ar) صور متعددة الأشكال
CL2018002298A1 (es) 2-oximidazolilcarboxamidas sustituidas como plaguicidas
CL2016002301A1 (es) Cry1d para controlar el gusano de la mazorca del maíz
MX374666B (es) Producto alimenticio y/o ingrediente alimenticio.
CO2018004582A2 (es) Alimentos para aves y, en particular, alimentos para aves de corral, que comprenden derivados sintéticos de capsaicinoides y dichos alimentos para el uso prohiláctico o el tratamiento de la infección por salmonela
KR101976519B9 (ko) 가축의 반추위를 모니터링하는 방법
EP3579687C0 (fr) Logette comprenant une structure guide pour la stabulation d'animaux tels que des bovins
CL2018003037A1 (es) 2-alquilimidazolilcarboxamidas sustituidas como plaguicidas.
CL2016001584A1 (es) Composiciones y métodos para aumentar la palatabilidad de alimentos secos para mascotas
ES2494617B1 (es) Uso de la Garvicina A como producto antimicrobiano
DK3407736T3 (da) Calciumberiget havdyrsprodukt
CL2013003808A1 (es) Formulacion veterinaria que comprende un extracto etanolico de s. adenotrichius dc donde el extracto etanolico comprende un compuesto sesquiterpeno eremofilano de formula i; uso para prevenir, controlar o eliminar garrapatas o sus larvas en un animal o humano, y en el entorno de los mismos.
MX387355B (es) Uso de un polifenol para disminuir el retardo del crecimiento.
GB2550750A (en) Anthelmintic compounds
CL2019003436A1 (es) Producto de alimentos para mascotas que contiene una sal de metal básica.
ES1203886Y (es) Comedero para animales
CL2015003780A1 (es) Compuestos derivados pirimido-isoquinolin-quinonas, sus sales, isomeros, tautomeros farmacéuticas aceptables; composiciones farmáceuticas; procedimiento de preparación; y su uso en el tratamiento de enfermedades bacterianas y bacterianas multirresistentes.
HUE055352T2 (hu) Rovarfehérjét tartalmazó készítmény nõi androgénhiány kezelésében történõ alkalmazásra
UA34549S (uk) Диван «matteo»

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2494617

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20150611

FD2A Announcement of lapse in spain

Effective date: 20210928